Dear shareholder, Dear Madam, Dear Sir, Please find attached our press release with the trading update for the first quarter of 2026, highlighting: Strong start to the year of the core participations Confirmation of guidance: net profit of 2026 is expected to be roughly in line with the record result of 2025 Positive net financial position of 410.8 million euros Best regards Ackermans & van Haaren...
Dear shareholder, Dear Madam, Dear Sir, Please find attached our press release with the trading update for the first quarter of 2026, highlighting: Strong start to the year of the core participations Confirmation of guidance: net profit of 2026 is expected to be roughly in line with the record result of 2025 Positive net financial position of 410.8 million euros Best regards Ackermans & van Haaren Attachment
Dear shareholder, Dear Madam, Dear Sir, Please find attached our press release with the FY2025 Results: Outstanding results at DEME, Delen Private Bank, Bank Van Breda and SIPEF boost net profit...
Dear shareholder, Dear Madam, Dear Sir, Please find attached our press release with the FY2025 Results: Outstanding results at DEME, Delen Private Bank, Bank Van Breda and SIPEF boost net profit...
Dear shareholder, Dear Madam, Dear Sir, Please find attached our press release with the FY2025 Results: Outstanding results at DEME, Delen Private Bank, Bank Van Breda and SIPEF boost net profit...
Dear shareholder, Dear Madam, Dear Sir, Please find attached our press release with the FY2025 Results: Outstanding results at DEME, Delen Private Bank, Bank Van Breda and SIPEF boost net profit...
tum3123/iStock via Getty Images Anu Rajakumar: When most investors think about emerging markets, they think top-down: country-level macro calls, currency bets, commodity cycles. They think growth, equating fast-growing economies with fast-growing portfolios. They tend to treat emerging markets as a monolithic block, one allocation, one thesis. But what if those assumptions are exactly what gets in...
tum3123/iStock via Getty Images Anu Rajakumar: When most investors think about emerging markets, they think top-down: country-level macro calls, currency bets, commodity cycles. They think growth, equating fast-growing economies with fast-growing portfolios. They tend to treat emerging markets as a monolithic block, one allocation, one thesis. But what if those assumptions are exactly what gets in the way of potential returns? What if the single most important variable in emerging market investing isn’t the macro backdrop but the price you pay? What if the best opportunities tend to show up precisely when fear and uncertainty are highest, which in a universe of 24 countries at different stages of development is almost always happening somewhere? My name is Anu Rajakumar, and today, I’m joined by two guests, Vera German and Juan Torres, portfolio managers on Neuberger’s Emerging Markets Equity team. We’ll talk about why a value lens may be the most natural and most overlooked way to approach emerging market equity, the misconceptions that shape how most investors think about the asset class, and where the most interesting pockets of opportunity are showing up today. Vera and Juan, welcome to the show. Vera German: Good to be here. Juan Torres: Thank you very much for having us. Anu Rajakumar: Juan, I want to start with something that you mentioned before we started recording, that you feel many investors are thinking about emerging market equity the wrong way. Tell us about what big misconception investors often have and why you think that investors should look at emerging markets with a different lens. Juan Torres: You mentioned something in the introduction about emerging markets not being a monolithic block. I think that that’s something that we’ve been hearing for a very long time, yet people keep thinking about the asset class as just this one big theme, and everyone is the same and equal. Actually, you have 24 different countries in very different parts of thei...
Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026. Group Overview Solid commercial momentum , particularly in IBA Technologies driven by RadioPharma Solutions, followed by an active pipeline in Proton Therapy. , particularly in IBA Technologies driven by RadioPharma...
Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026. Group Overview Solid commercial momentum , particularly in IBA Technologies driven by RadioPharma Solutions, followed by an active pipeline in Proton Therapy. , particularly in IBA Technologies driven by RadioPharma Solutions, followed by an active pipeline in Proton Therapy. Backlog stable at €1.6 billion , including €0.73 billion and €0.83 billion in equipment and services backlog respectively. including €0.73 billion and €0.83 billion in equipment and services backlog respectively. FY2026 adjusted EBIT guidance reaffirmed of at least €32 million, reflecting confidence in the Group’s full-year outlook. reflecting confidence in the Group’s full-year outlook. Net debt position stable at €57 million 1 as of March 31, 2026 , with €15 million of revolving credit facilities used. Working capital cycle remains driven by large proton therapy project deliveries, with share buyback progress and anticipated supplier payments (related to the new ERP system go-live) further contributing to this evolution. Net financial position expected to remain broadly stable in H1 2026, before progressively improving in H2 2026, with acceleration in 2027. as of March 31, 2026 with €15 million of revolving credit facilities used. Working capital cycle remains driven by large proton therapy project deliveries, with share buyback progress and anticipated supplier payments (related to the new ERP system go-live) further contributing to this evolution. Net financial position expected to remain broadly stable in H1 2026, before progressively improving in H2 2026, with acceleration in 2027. PanTera reached three key regulatory milestones for pharmaceutical-grade actinium-225 supply, supporting clinical partners in targeted alpha therapy programs. Olivier Legrain, Chief Executive Officer of IBA commented: “We are ple...
Louvain-la-Neuve, Belgique, le 21 mai 2026 - IBA (Ion Beam Applications SA), le leader mondial des technologies d’accélération de particules, publie aujourd'hui la revue de ses activités pour le premier trimestre 2026.
Louvain-la-Neuve, Belgique, le 21 mai 2026 - IBA (Ion Beam Applications SA), le leader mondial des technologies d’accélération de particules, publie aujourd'hui la revue de ses activités pour le premier trimestre 2026.
(RTTNews) - Singapore Telecommunications Ltd., or Singtel Group (Z74.SI, SGAPY, Z77.SI) reported Thursday higher profit in fiscal 2026, mainly benefited by a gain from stake sale, amid slightly higher revenues. Further, the company lifted annual dividend. Looking ahead, the company said it is taking a more cautious near-term outlook, with EBIT growth expected to be between low and mid-single digit...
(RTTNews) - Singapore Telecommunications Ltd., or Singtel Group (Z74.SI, SGAPY, Z77.SI) reported Thursday higher profit in fiscal 2026, mainly benefited by a gain from stake sale, amid slightly higher revenues. Further, the company lifted annual dividend. Looking ahead, the company said it is taking a more cautious near-term outlook, with EBIT growth expected to be between low and mid-single digits due to the Middle East uncertainty. Total capital expenditure is projected to be around S$3.0 billion. Core capital expenditure is expected to remain stable at around S$1.8 billion. An additional S$1.2 billion will primarily be invested in data centres. In Singapore, the shares were trading at S$4.7500, down 5.4 percent. In the full year, net profit attributable to shareholders grew 40 percent to S$5.61 billion from last year's S$4.02 billion. Earnings per share were 33.62 cents, up from 23.92 cents a year ago. The improvement in result reflected a net exceptional gain of S$2.84 billion mainly from stake sales in Airtel, which was partly offset by various provisions largely from Australia. Underlying net profit grew 12 percent year-over-year to S$2.77 billion, driven mainly by regional associates Airtel and AIS and operating companies NCS, Digital InfraCo and Optus. Profit on operating activities increased to S$4.58 billion from S$2.37 billion a year ago. Both EBITDA and operating company EBIT rose 2 percent and 9 percent, respectively, due to the robust performances of NCS, Digital InfraCo and Optus. Operating revenue was S$14.26 billion, slightly higher than S$14.15 billion a year earlier. Further, the Directors have proposed a final one-tier tax exempt ordinary dividend of 10.3 cents per share, consisting of a core dividend of 7.0 cents per share; and a value realisation dividend of 3.3 cents per share. The aggregate ordinary dividends for the year ended March 31, 2026 would increase by 9 percent from last year to 18.5 cents per share. For more earnings news, earnings ...
Wirestock/iStock Editorial via Getty Images In my last analysis , I rated JPMorgan Chase ( JPM ) a Strong Buy with a $366–$405 price target for 2026, driven by the strategic integration of the Apple Card portfolio. That thesis was focused on the acquisition that temporarily spiked Advanced Risk-Weighted Assets [RWA] by $110 billion , but a possible normalization to ~$30 billion may open up $9–$10 ...
Wirestock/iStock Editorial via Getty Images In my last analysis , I rated JPMorgan Chase ( JPM ) a Strong Buy with a $366–$405 price target for 2026, driven by the strategic integration of the Apple Card portfolio. That thesis was focused on the acquisition that temporarily spiked Advanced Risk-Weighted Assets [RWA] by $110 billion , but a possible normalization to ~$30 billion may open up $9–$10 billion in CET1 capital. This unpriced catalyst may back strong share buybacks or high-yield lending that may possibly push ROCE beyond JPMorgan Chase's 17% target. However, a hard $105 billion expense floor risks operating leverage if net interest income gets damaged by it. Under that analysis, JPMorgan Chase’s fortress balance sheet and accelerated capital return pace point out a highly strong and technically cross-checked upside. Now, I put a Hold rating (on long positions) on JPMorgan Chase stock. To expand more on the reasoning behind this Hold (a downgrade), although JPMorgan Chase operates as a sovereign-level financial utility, the current peak valuations fully priced in short-term fundamental edge. This forward thesis balances big structural tailwinds against possible regulatory capital traps. On the bullish side, the Q2-FY2026 Visa B-2 equity exchange may scale up billions in fair-value gains and provide a large covert chest to front-load $19.8 billion in AI/tech investments without breaching (higher) the $105 billion expense guidance . At the same time, JPMorgan Chase’s $1.5 trillion Security and Resiliency Initiative [SRI] backs its leading motion on the AI infrastructure financing super-cycle. However, these tailwinds are mostly counterbalanced by a hard regulatory headwind that is a projected $13 billion G-SIB capital penalty by FY2028, targeting short-term wholesale funding. This mandate risks compressing the ROE of JPMorgan Chase’s Progressive Markets division. Along with late-cycle subprime exposure from the impending Apple Card integration, the risk-reward...
Kenneth Cheung Airbnb ( ABNB ) CEO Brian Chesky said the company could evolve into an Amazon-like platform for travel services as it positions itself as an ' everything' app for traveling and living, embedding AI for trip planning, recommendations, and broadening into car rentals. "I imagine one day we’ll have dozens, possibly even hundreds of categories, just like Amazon," CEO Brian Chesky told C...
Kenneth Cheung Airbnb ( ABNB ) CEO Brian Chesky said the company could evolve into an Amazon-like platform for travel services as it positions itself as an ' everything' app for traveling and living, embedding AI for trip planning, recommendations, and broadening into car rentals. "I imagine one day we’ll have dozens, possibly even hundreds of categories, just like Amazon," CEO Brian Chesky told CNBC , "I think we can build a little bit, like an Amazon for services, at least for traveling and living." Airbnb ( ABNB ) expanded its platform beyond home rentals, adding independent hotels along with new services, including car rentals, grocery delivery, and luggage storage, to its app. The rollout marks the latest step in Airbnb ’s ( ABNB ) effort to capture a larger share of travel spending that currently flows to competitors such as Booking Holdings ( BKNG ) and Expedia Group ( EXPE ). Chesky added that the company may eventually include additional services, including equipment rentals for activities such as surfing and skiing, as well as gym passes down the road. The holiday maker is also upgrading its AI strategy this year with new features across its chatbot and platform experiences. Later this year, Airbnb ( ABNB ) plans to introduce an AI voice assistant for its chatbot, along with AI-generated summaries for property listings. More on Airbnb Airbnb Q1 2026 Earnings: Growth Acceleration Despite War Headwind Airbnb, Inc. (ABNB) Q1 2026 Earnings Call Transcript Airbnb: At $140 Into Q1 Earnings I Would Sell Airbnb sits sixth in travel's Quant rankings, in contrast to strong Q1 results Airbnb targets at least 35% adjusted EBITDA margin as it raises 2026 revenue growth to low-to-mid teens
21 May 2026 UPDATE Groundbreaking health features available today on Apple Watch and AirPods Pro Apple Watch delivers sleep apnoea notifications and AirPods Pro provide a clinically validated Hearing Test feature to users in India Starting today, sleep apnoea notifications come to Apple Watch, adding to the many ways Apple Watch acts as an intelligent guardian for users’ health.1 Additionally, Air...
21 May 2026 UPDATE Groundbreaking health features available today on Apple Watch and AirPods Pro Apple Watch delivers sleep apnoea notifications and AirPods Pro provide a clinically validated Hearing Test feature to users in India Starting today, sleep apnoea notifications come to Apple Watch, adding to the many ways Apple Watch acts as an intelligent guardian for users’ health.1 Additionally, AirPods Pro 3 provide a clinically validated Hearing Test feature for users to test their hearing levels in the comfort of their own home.2 “At Apple, we believe technology should empower people to take control of their health, and that starts with giving users tools to detect conditions they may not even know they have,” said Sumbul Desai, M.D., Apple’s vice president of Health and Fitness. “From sleep apnoea notifications on Apple Watch to a hearing test with AirPods Pro, we’re excited to bring these meaningful capabilities to our users in India.” A Powerful Way to Detect Signs of Sleep Apnoea Sleep is an important area of health as it impacts a person’s overall physical and mental wellbeing. Sleep apnoea is a prevalent disorder in which breathing momentarily stops during sleep, preventing the body from getting enough oxygen. The condition is estimated to impact more than 1 billion people worldwide, and in most cases, goes undiagnosed.3 If left untreated, it can have important health consequences over time, including increased risk of hypertension, type 2 diabetes, and cardiac issues.4 Breathing Disturbances is an innovative new Apple Watch metric that uses the accelerometer to detect small movements at the wrist associated with interruptions to normal respiratory patterns during sleep. Every 30 days, Apple Watch will analyse breathing disturbance data and notify users if it shows consistent signs of moderate to severe sleep apnoea so they can speak to their doctor about next steps, including potential diagnosis and treatment. For more informed conversations with their healt...